UBS Faces Crucial Week of Earnings and Regulatory Decisions
UBS reports Q1 2026 results amid a Swiss regulatory clash over $22B in extra capital. Shareholders backed dividends…
UBS Shareholders Await Crucial April Decisions
UBS navigates final Swiss capital rules, a pivotal AGM, and Q1 earnings to prove Credit Suisse integration success…
UBS Board Refresh Signals Strategic Shift Ahead of Key Regulatory Decisions
UBS reshapes its board with BIS and Apple executives ahead of key Q1 2026 results and stricter Swiss…
UBS Board Refresh Signals Strategic Shift Ahead of Key Regulatory Decisions
UBS reshapes its board with BIS and Apple executives ahead of key Q1 2026 results and stricter Swiss…
Shareholders Await Key Decisions on Capital and Leadership
UBS faces a pivotal April with its AGM, a key Swiss capital requirement decision, and Q1 earnings. Shareholders…
Legal transparency, timeliness and trust restoration after a global safety failure
This month has seen Nestlé, Lactalis and Danone embroiled in a major recall impacting baby formula. Now, both…